SCHEMBL6054233

SCHEMBL6054233

CCOC(=O)c1cn2ncc(C#N)c(Nc3ccc(Oc4ccccn4)cc3)c2c1C

nearest known ligand 0.81

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 20/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3693846 0.91 MAP2K1 (0.82) MAP2K1
SCHEMBL3692710 0.90 MAP2K1 (1.00) MAP2K1
SCHEMBL3690055 0.89 MAP2K1 (0.83) MAP2K1
SCHEMBL6054361 0.88 MAP2K1 (0.85) MAP2K1
SCHEMBL3688790 0.87 MAP2K1 (0.87) MAP2K1
SCHEMBL3690845 0.86 MAP2K1 (0.72) MAP2K1
SCHEMBL3693408 0.86 MAP2K1 (1.00) MAP2K1
SCHEMBL6054278 0.86 MAP2K1 (0.86) MAP2K1
SCHEMBL3693390 0.86 MAP2K1 (0.85) MAP2K1
SCHEMBL3688321 0.85 MAP2K1 (0.84) MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030112-B2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-18 US claimed
US-7030112-B2 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-18 US disclosed